Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The canonical pathway mediating the effects of sulforaphane is the KEAP1-NRF2 pathway, sometimes referred to as the NRF2 pathway. This signaling cascade regulates cellular adaptation to oxidative and chemical stress, centering on the NRF2 transcription factor, which—when liberated from KEAP1-mediated degradation—translocates to the nucleus and induces the expression of a battery of antioxidant and detoxifying enzymes. Sulforaphane is the most potent natural activator of this pathway, and it exerts its cytoprotective, anti-inflammatory, and chemopreventive effects primarily through this mechanism. The pathway is critical for defense against a variety of chronic diseases, including cancer and neurodegeneration[2][4][7].
Activation of NRF2 transcription factor (often by modifying cysteines on KEAP1, releasing NRF2 to translocate to the nucleus)\nUpregulation of antioxidant and detoxification genes\nInhibition of pro-inflammatory NF-κB signaling
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nuclear factor erythroid 2-related factor 2 pathway (NRF2 pathway).